Tine Dahlbaek Hannibal

Tine Dahlbaek Hannibal

Auto-generated profile, based on publicly available information

Tine Dahlbaek Hannibal

Department of Experimental Medical Science, Lund University, Lund, Sweden

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2017 in Diabetologia
Verified
Journal Article
Open access
PDF file
THTine D. Hannibal
Tine D. Hannibal
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
JNJulia Nilsson
Julia Nilsson
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
LHLisbeth Hansen
Lisbeth Hansen
DHDan Holmberg
Dan Holmberg
Aims/hypothesis Obesity is associated with glucose intolerance and insulin resistance and is closely linked to the increasing prevalence of type 2 diabetes. In mouse models of diet-induced obesity (DIO) and type 2 diabetes, an increased fat intake results in adipose tissue expansion and the secretion of proinflammatory cytokines. The innate immune system not only plays a crucial role in obesity-associated chronic low-grade inflammation but it is also proposed to play a role in modulating energy metabolism. However, little is known about how the modulation of metabolism by the immune system may promote increased adiposity in the early stages of increased dietary intake. Here we aimed to define the role of type I IFNs in DIO and insulin resistance. Methods Mice lacking the receptor for IFN-α (IFNAR−/−) and deficient in plasmacytoid dendritic cells (pDCs) (B6.E2-2fl/fl.Itgax-cre) were fed a diet with a high fat content or normal chow. The mice were analysed in vivo and in vitro using cellular, biochemical and molecular approaches. Results We found that the development of obesity was inhibited by an inability to respond to type I IFNs. Furthermore, the development of obesity and insulin resistance in this model was associated with pDC recruitment to the fatty tissues and liver of obese mice (a 4.3-fold and 2.7-fold increase, respectively). Finally, we demonstrated that the depletion of pDCs protects mice from DIO and from developing obesity-associated metabolic complications. Conclusions/interpretation Our results provide genetic evidence that pDCs, via type I IFNs, regulate energy metabolism and promote the development of obesity.

5 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NPNina Fransén Pettersson
Nina Fransén Pettersson
ADAdnan Deronic
Adnan Deronic
JNJulia Nilsson
Julia Nilsson
THTine D Hannibal
Tine D Hannibal
LHLisbeth Hansen
Lisbeth Hansen
DHDan Holmberg
Dan Holmberg
Quinoline-3-carboxamides (Q substances) are small molecule compounds with anti-inflammatory properties. In this study, we used one of these substances, Paquinimod, to treat a novel model for chronic liver inflammation and liver fibrosis, the NOD-Inflammation Fibrosis (N-IF) mouse. We show that treatment of N-IF mice significantly reduced inflammation and resulted in the regression of fibrosis, even when the treatment was initiated after onset of disease. The reduced disease phenotype was associated with a systemic decrease in the number and reduced activation of disease-promoting transgenic natural killer T (NKT)-II cells and their type 2-cytokine expression profile. Paquinimod treatment also led to a reduction of CD115+ Ly6Chi monocytes and CD11b+ F4/80+ CD206+ macrophages.

21 August 2013 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
LHLisbeth Hansen
Lisbeth Hansen
EIErwin Ilegems
Erwin Ilegems
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
UDUlf Dahl
Ulf Dahl
DHDan Holmberg
Dan Holmberg

1 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LHLisbeth Hansen
Lisbeth Hansen
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
SGShashank Gupta
Shashank Gupta
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
THTine D. Hannibal
Tine D. Hannibal
DHDan Holmberg
Dan Holmberg
Autoimmune diabetes is a consequence of immune-cell infiltration and destruction of pancreatic β-cells in the islets of Langerhans. We analyzed the cellular composition of the insulitic lesions in the autoimmune-prone non-obese diabetic (NOD) mouse and observed a peak in recruitment of plasmacytoid dendritic cells (pDCs) to NOD islets around 8–9 weeks of age. This peak coincides with increased spontaneous expression of type-1-IFN response genes and CpG1585 induced production of IFN-α from NOD islets. The transcription factor E2-2 is specifically required for the maturation of pDCs, and we show that knocking out E2-2 conditionally in CD11c+ cells leads to a reduced recruitment of pDCs to pancreatic islets and reduced CpG1585 induced production of IFN-α during insulitis. As a consequence, insulitis has a less aggressive expression profile of the Th1 cytokine IFN-γ and a markedly reduced diabetes incidence. Collectively, these observations demonstrate a disease-promoting role of E2-2 dependent pDCs in the pancreas during autoimmune diabetes in the NOD mouse.

21 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
NDNadia Duarte
Nadia Duarte
JNJulia Nilsson
Julia Nilsson
MLMarie Lundholm
Marie Lundholm
SMSofia Mayans
Sofia Mayans
DHDan Holmberg
Dan Holmberg
Here we characterize a new animal model that spontaneously develops chronic inflammation and fibrosis in multiple organs, the non-obese diabetic inflammation and fibrosis (N-IF) mouse. In the liver, the N-IF mouse displays inflammation and fibrosis particularly evident around portal tracts and central veins and accompanied with evidence of abnormal intrahepatic bile ducts. The extensive cellular infiltration consists mainly of macrophages, granulocytes, particularly eosinophils, and mast cells. This inflammatory syndrome is mediated by a transgenic population of natural killer T cells (NKT) induced in an immunodeficient NOD genetic background. The disease is transferrable to immunodeficient recipients, while polyclonal T cells from unaffected syngeneic donors can inhibit the disease phenotype. Because of the fibrotic component, early on-set, spontaneous nature and reproducibility, this novel mouse model provides a unique tool to gain further insight into the underlying mechanisms mediating transformation of chronic inflammation into fibrosis and to evaluate intervention protocols for treating conditions of fibrotic disorders.

5 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGShashank Gupta
Shashank Gupta
RURegine Utoft
Regine Utoft
HHHenrik Hasseldam
Henrik Hasseldam
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
THTine Dahlbaek Hannibal
Tine Dahlbaek Hannibal
DHDan Holmberg
Dan Holmberg
Multiple Sclerosis (MS) is a progressive autoimmune inflammatory and demyelinating disease of the central nervous system (CNS). T cells play a key role in the progression of neuroinflammation in MS and also in the experimental autoimmune encephalomyelitis (EAE) animal models for the disease. A technology for quantitative and 3 dimensional (3D) spatial assessment of inflammation in this and other CNS inflammatory conditions is much needed. Here we present a procedure for 3D spatial assessment and global quantification of the development of neuroinflammation based on Optical Projection Tomography (OPT). Applying this approach to the analysis of rodent models of MS, we provide global quantitative data of the major inflammatory component as a function of the clinical course. Our data demonstrates a strong correlation between the development and progression of neuroinflammation and clinical disease in several mouse and a rat model of MS refining the information regarding the spatial dynamics of the inflammatory component in EAE. This method provides a powerful tool to investigate the effect of environmental and genetic forces and for assessing the therapeutic effects of drug therapy in animal models of MS and other neuroinflammatory/neurodegenerative disorders.